Drugs in Context : Impact Factor & More
eISSN: 1740-4398pISSN: 1745-1981
Open AccessShare this on:
Key Metrics
CiteScore 
8.1
SNIP
1.92
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Drugs in Context
Drugs in Context Journal Specifications
| Overview | |
| Publisher | BioExcel Publishing Ltd |
| Language | English |
| Article Processing Charges | GBP 1550 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Drugs in Context ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs in Context
Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma.
- 23 Feb 2026
- Drugs in context
Corrigendum: Role of a topical hydrogel (Dermatix® wound care gel) in acute and chronic wound management: a case series of real-world experiences and expert opinion from Asia.
- 17 Feb 2026
- Drugs in context
Emerging concepts in HIV pre-exposure prophylaxis: focus on twice-yearly lenacapavir
- 5 Feb 2026
- Drugs in Context
Ustekinumab-associated morphoea: systematic review of the literature and a real-world case
- 3 Feb 2026
- Drugs in Context
The convergent pathway of obstructive lung disease: the disease-modifying potential of dipeptidyl peptidase 1 inhibition in COPD, asthma and bronchiectasis overlap
- 29 Jan 2026
- Drugs in Context
Optimizing care and quality indicators in the management of patients with acute ischaemic heart disease and atherothrombotic stroke: measuring to improve
- 27 Jan 2026
- Drugs in Context
Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma.
- 23 Feb 2026
- Drugs in context
Corrigendum: Role of a topical hydrogel (Dermatix® wound care gel) in acute and chronic wound management: a case series of real-world experiences and expert opinion from Asia.
- 17 Feb 2026
- Drugs in context
Emerging concepts in HIV pre-exposure prophylaxis: focus on twice-yearly lenacapavir
- 5 Feb 2026
- Drugs in Context
Ustekinumab-associated morphoea: systematic review of the literature and a real-world case
- 3 Feb 2026
- Drugs in Context
The convergent pathway of obstructive lung disease: the disease-modifying potential of dipeptidyl peptidase 1 inhibition in COPD, asthma and bronchiectasis overlap
- 29 Jan 2026
- Drugs in Context
Optimizing care and quality indicators in the management of patients with acute ischaemic heart disease and atherothrombotic stroke: measuring to improve
- 27 Jan 2026
- Drugs in Context
FAQs on Drugs in Context
How many articles did Drugs in Context publish last year? 
What is the eISSN & pISSN for Drugs in Context?
What is Citescore for Drugs in Context?
What is SNIP score for Drugs in Context?
Who is the publisher of Drugs in Context?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations